117 related articles for article (PubMed ID: 37906601)
21. Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis.
Deng J; Wu Z; Zhao Z; Wu C; Yuan M; Su Z; Wang Y; Wang Z
Int J Nanomedicine; 2020; 15():3937-3951. PubMed ID: 32581538
[TBL] [Abstract][Full Text] [Related]
22. Lipid-based nano-formulation platform for eplerenone oral delivery as a potential treatment of chronic central serous chorioretinopathy:
Abd-Elhakeem E; El-Nabarawi M; Shamma R
Drug Deliv; 2021 Dec; 28(1):642-654. PubMed ID: 33787445
[TBL] [Abstract][Full Text] [Related]
23. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
Das S; Ng WK; Tan RB
Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
[TBL] [Abstract][Full Text] [Related]
24. Novel Nanostructured Lipid Carriers Co-Loaded with Mesalamine and Curcumin: Formulation, Optimization and In Vitro Evaluation.
Awasthi A; Kumar B; Gulati M; Vishwas S; Corrie L; Kaur J; Khursheed R; Muhammed RA; Kala D; Porwal O; Babu MR; Chaitanya MVNL; Kumar A; Pandey NK; Dureja H; Chellappan DK; Jha NK; Gupta G; Prasher P; Kumar D; Dua K; Singh SK
Pharm Res; 2022 Nov; 39(11):2817-2829. PubMed ID: 36195824
[TBL] [Abstract][Full Text] [Related]
25. Fabrication of Mupirocin-Loaded Nanostructured Lipid Carrier and Its
Singh AP; Sharma SK; Gaur PK; Gupta DK
Assay Drug Dev Technol; 2021; 19(4):216-225. PubMed ID: 33781090
[No Abstract] [Full Text] [Related]
26. Co-Delivery of erlotinib and resveratrol via nanostructured lipid Carriers: A synergistically promising approach for cell proliferation prevention and ROS-Mediated apoptosis activation.
Asadollahi L; Mahoutforoush A; Dorreyatim SS; Soltanfam T; Paiva-Santos AC; Peixoto D; Veiga F; Hamishehkar H; Zeinali M; Abbaspour-Ravasjani S
Int J Pharm; 2022 Aug; 624():122027. PubMed ID: 35850183
[TBL] [Abstract][Full Text] [Related]
27. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
Noor NM; Sheikh K; Somavarapu S; Taylor KMG
Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
[TBL] [Abstract][Full Text] [Related]
28. Process, optimization, and characterization of budesonide-loaded nanostructured lipid carriers for the treatment of inflammatory bowel disease.
Sinhmar GK; Shah NN; Chokshi NV; Khatri HN; Patel MM
Drug Dev Ind Pharm; 2018 Jul; 44(7):1078-1089. PubMed ID: 29376433
[TBL] [Abstract][Full Text] [Related]
29. Eudragit S-100 Surface Engineered Nanostructured Lipid Carriers for Colon Targeting of 5-Fluorouracil: Optimization and In Vitro and In Vivo Characterization.
Borderwala K; Rathod S; Yadav S; Vyas B; Shah P
AAPS PharmSciTech; 2021 Aug; 22(6):216. PubMed ID: 34386888
[TBL] [Abstract][Full Text] [Related]
30. Rifampicin loaded mannosylated cationic nanostructured lipid carriers for alveolar macrophage-specific delivery.
Song X; Lin Q; Guo L; Fu Y; Han J; Ke H; Sun X; Gong T; Zhang Z
Pharm Res; 2015 May; 32(5):1741-51. PubMed ID: 25407545
[TBL] [Abstract][Full Text] [Related]
31. Meropenem-Loaded Nanostructured Lipid Carriers For Skin and Soft Tissue Infection Caused by Staphylococcus aureus: Formulation, Design, and Evaluation.
Rajpoot K; Prajapati SK; Malaiya A; Jain R; Jain A
AAPS PharmSciTech; 2022 Aug; 23(7):241. PubMed ID: 36008695
[TBL] [Abstract][Full Text] [Related]
32. Nose to Brain Delivery of Astaxanthin-Loaded Nanostructured Lipid Carriers in Rat Model of Alzheimer's Disease: Preparation, in vitro and in vivo Evaluation.
Shehata MK; Ismail AA; Kamel MA
Int J Nanomedicine; 2023; 18():1631-1658. PubMed ID: 37020692
[TBL] [Abstract][Full Text] [Related]
33. Anti-oxidant Containing Nanostructured Lipid Carriers of Ritonavir: Development, Optimization, and In Vitro and In Vivo Evaluations.
Jitta SR; Bhaskaran NA; Salwa ; Kumar L
AAPS PharmSciTech; 2022 Mar; 23(4):88. PubMed ID: 35296970
[TBL] [Abstract][Full Text] [Related]
34. Quality by Design Approach for Preparation of Zolmitriptan/Chitosan Nanostructured Lipid Carrier Particles - Formulation and Pharmacodynamic Assessment.
Awadeen RH; Boughdady MF; Meshali MM
Int J Nanomedicine; 2020; 15():8553-8568. PubMed ID: 33173292
[TBL] [Abstract][Full Text] [Related]
35. Targeted Nanostructured Lipid Carrier for Brain Delivery of Artemisinin: Design, Preparation, Characterization, Optimization and Cell Toxicity.
Emami J; Yousefian H; Sadeghi H
J Pharm Pharm Sci; 2018; 21(1s):225s-241s. PubMed ID: 30266137
[TBL] [Abstract][Full Text] [Related]
36. Pectin coated nanostructured lipid carriers for targeted piperine delivery to hepatocellular carcinoma.
Shehata EMM; Gowayed MA; El-Ganainy SO; Sheta E; Elnaggar YSR; Abdallah OY
Int J Pharm; 2022 May; 619():121712. PubMed ID: 35367582
[TBL] [Abstract][Full Text] [Related]
37. Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers.
Wang W; Chen L; Huang X; Shao A
AAPS PharmSciTech; 2017 Feb; 18(2):509-516. PubMed ID: 27120090
[TBL] [Abstract][Full Text] [Related]
38. S-Protected thiolated nanostructured lipid carriers exhibiting improved mucoadhesive properties.
Arshad S; Masood-Ur-Rehman ; Hussain Asim M; Nazir I; Shahzadi I; Mousli M; Bernkop-Schnürch A
Int J Pharm; 2020 Sep; 587():119690. PubMed ID: 32738459
[TBL] [Abstract][Full Text] [Related]
39. Nanostructured lipid carriers incorporating prickly pear seed oil for the encapsulation of vitamin A.
AlZahabi S; Sakr OS; Ramadan AA
J Cosmet Dermatol; 2019 Dec; 18(6):1875-1884. PubMed ID: 30784168
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of bioavailability through transdermal drug delivery of paliperidone palmitate-loaded nanostructured lipid carriers.
Raval S; Jani P; Patil P; Thakkar P; Sawant K
Ther Deliv; 2021 Aug; 12(8):583-596. PubMed ID: 34286598
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]